G
Monte Rosa Therapeutics (GLUE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Monte Rosa Therapeutics (GLUE)
Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.
- USD5.82
- USD5.85
- USD5.64
- USD8.84
- -18.50%
- --
- 80.63k
- 119.81k
- 267M
- 2.44
- 15.10%
Stock News
4 hours ago
Former Boeing CEO and Seattle Mariners co-owner Frank Shrontz dies aged 92
Yahoo
4 hours ago
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
CNBC
4 hours ago
Is Boeing Stock a Buy?
Yahoo
5 hours ago
Should You Buy ChargePoint While More Money Is Going Out Than Coming In?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
